Gisela Lorente is currently the Chief Executive Officer at Aptadel Therapeutics, having previously held roles such as Chief Scientific Officer and Acting CEO at the same company. Gisela also serves as the AECC Innova external evaluator at the Asociación Española contra el Cáncer. With a background in biomedicine and molecular biology, Gisela has experience in innovation, technology transfer, business development, and project management within the biomedical research and healthcare innovation sectors. Gisela has also served as a researcher, teacher, and advisory board member in various organizations and institutions.
Sign up to view 2 direct reports
Get started
This person is not in any teams